Amicus Therapeutics, Inc. (FOLD) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Join SI Premium – FREE
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.07 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Sonoma Pharmaceuticals (SNOA) Misses Q4 EPS by 33c
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
